|
End-of-day quote
Other stock markets
|
||
| - | - |
|
| 07-13 | BMO Capital Adjusts Price Target on Pfizer to $30 From $34, Maintains Outperform Rating | MT |
| 07-12 | Pfizer, Astellas Secure FDA Nod For Bladder Cancer Drug | MT |
| Market Cap | 140B 0 123B 114B 105B 197B 13,341B 202B 1,355B 531B 6,556B 524B 512B 22,658B | P/E 2026 * |
12.4x | P/E 2027 * | 12.9x |
|---|---|---|---|---|---|
| Enterprise Value | 189B 0 166B 154B 141B 267B 18,055B 273B 1,834B 718B 8,872B 709B 693B 30,664B | EV / Sales 2026 * |
3.06x | EV / Sales 2027 * | 3.08x |
| Free-Float |
59.06% | Yield 2026 * |
7.05% | Yield 2027 * | 7.12% |
Last Transcript: PFIZER
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 2018-12-31 |
David Denton
DFI | Director of Finance/CFO | 60 | 2022-05-01 |
| Chief Tech/Sci/R&D Officer | - | 2006-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 2007-08-31 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 2013-09-26 |
Albert Bourla
CHM | Chairman | 64 | 2019-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.56% | -2.64% | +49.04% | +168.24% | 1,060B | |
| +0.31% | -2.00% | +64.29% | +63.06% | 619B | |
| -0.03% | -5.01% | +28.86% | +83.73% | 438B | |
| -1.75% | -2.91% | +28.78% | +24.35% | 333B | |
| +0.24% | -2.61% | +29.46% | +46.50% | 282B | |
| -1.75% | -12.77% | +20.67% | +23.05% | 267B | |
| +0.67% | -0.76% | -26.10% | -37.25% | 218B | |
| -0.81% | -3.66% | +22.07% | +59.72% | 196B | |
| +1.21% | +0.10% | +19.85% | +72.03% | 161B | |
| Average | -0.23% | -3.33% | +26.32% | +55.94% | 397.1B | |
| Weighted average by Cap. | -0.28% | -3.10% | +36.27% | +82.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 61.74B 0 54.24B 50.3B 46.25B 87.34B 5,904B 89.26B 600B 235B 2,901B 232B 227B 10,027B | 59.36B 0 52.15B 48.36B 44.46B 83.97B 5,676B 85.81B 577B 226B 2,789B 223B 218B 9,640B |
| Net income | 10.63B 0 9.34B 8.66B 7.96B 15.03B 1,016B 15.36B 103B 40.41B 499B 39.9B 39.03B 1,726B | 10.27B 0 9.02B 8.36B 7.69B 14.52B 982B 14.84B 99.72B 39.05B 482B 38.55B 37.71B 1,667B |
| Net Debt | 49.3B 0 43.31B 40.16B 36.93B 69.73B 4,714B 71.26B 479B 187B 2,316B 185B 181B 8,006B | 43.17B 0 37.92B 35.17B 32.33B 61.06B 4,128B 62.4B 419B 164B 2,028B 162B 159B 7,010B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- PFE Stock
- PFZ Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
